PW Medtech Group (HKSE:01358) EPS (Diluted) : HK$0.11 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group EPS (Diluted)?

PW Medtech Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.06. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.11.

PW Medtech Group's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.11.

PW Medtech Group's EPS without NRI for the six months ended in Dec. 2023 was HK$0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.11.

During the past 12 months, PW Medtech Group's average EPS without NRIGrowth Rate was 44.70% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -12.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, PW Medtech Group's highest 3-Year average EPS without NRI Growth Rate was 87.60% per year. The lowest was -42.00% per year. And the median was -2.50% per year.

PW Medtech Group EPS (Diluted) Historical Data

The historical data trend for PW Medtech Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group EPS (Diluted) Chart

PW Medtech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

0.06

0.48

0.58

0.08

0.11

PW Medtech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															-0.02	0.05	0.03	0.05	0.06

Competitive Comparison of PW Medtech Group's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, PW Medtech Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PW Medtech Group's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's PE Ratio falls into.

PW Medtech Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

PW Medtech Group's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(167.549	-	0)	/	1565.632
	=	0.11

PW Medtech Group's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(89.917	-	0)	/	1565.632
	=	0.06

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.11

PW Medtech Group (HKSE:01358) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PW Medtech Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (HKSE:01358) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

PWE:Germany

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

Executives

Right Faith Holdings Limited	2101 Beneficial owner
Chan Marc	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc	2101 Beneficial owner
Cross Mark Limited	2101 Beneficial owner
Liu Yufeng	2201 Interest of corporation controlled by you
Zhang Zaixian	2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines